Ferritin Quantitative Test

Ferritin Rapid Quantitative Test (Chemiluminescence Immunoassay)

Ferritin Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Ferritin concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of malignant tumor or inflammation.

Product Detail

Application

Ferritin is a soluble tissue protein that stores iron in the human body. It is the most iron-rich protein complex, with a molecular weight of about 450,000 and containing 17% to 23% iron. Ferritin exists in various tissues and cells, especially in the liver, spleen, bone marrow, brain, and peripheral blood cells, including red blood cells, white blood cells, and platelets. Normal human serum contains a small amount of ferritin.

 

Ferritin plays an important dual role in the human body. It serves as a "reservoir" of iron for hemoglobin synthesis, and it also acts as a hollowed-in spherical protein that protects cells from excessive amounts of free iron, which can cause harmful effects.

 

Certain conditions can lead to increased ferritin levels in the body:

1. Acute infections and inflammatory diseases can promote the production of ferritin, the natural iron storage protein.

2. Hyperthyroidism can also cause ferritin to rise.

3. The increase of ferritin in malignant tumors is due to tumor invasion and necrosis, as well as the reduced ability of the liver to clear ferritin, and the increased synthesis of ferritin in tumor cells.

 

Specific types of cancer that can increase ferritin levels include:

Acute non-lymphocytic leukemia

Lymphoma

Liver cancer

Pancreatic cancer

Lung cancer

 

However, esophageal cancer, stomach cancer, colon cancer, and urinary system malignancies do not significantly affect ferritin levels.

 

Serum ferritin measurement can be used as a therapeutic indicator. Serum ferritin levels decrease in patients with effective treatment, but increase in patients with deterioration and recurrence. Continued increase in ferritin levels is associated with a poor prognosis. Therefore, serum ferritin measurement can be particularly useful for patients with alpha-fetoprotein-negative conditions.

 

Product Specification

Sample Volume

WB: 20μL; Serum/Plasma: 10μL

Test Time

10 mins

Measuring Range

0.50-1000 ng/mL

Pack

20T40T100T

Storage

2~30

 

Features

Smart - Photosensitive and Luminescent Microspheres

Rapid - Whole Blood Sample Type Supported & No Centrifuge Needed

Convenient - Room Temperature Storage & Minimal sample consumption

 

Clinical significance

Iron Deficiency Anemia Diagnosis

Monitoring Iron Status

Evaluation of Fatigue and Weakness

Assessment of Hemochromatosis

Guiding Iron Supplementation

Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
25(OH) D Rapid Quantitative Test (Chemiluminescence Immunoassay)
25(OH) D Rapid Quantitative Test (Chemiluminescence Immunoassay)
25(OH) D Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the 25-hydroxyvitamin D (25 (OH) D) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of health check.
Biotime NT-proBNP Rapid Quantitative Test
NT-proBNP Rapid Quantitative Test
NT-proBNP is a marker for detecting heart function, with a long half-life and high specificity. Biotime NT-proBNP test kit detects the amount of NT-proBNP in human whole blood, serum and plasma samples.
hs-cTnI Rapid Quantitative Test (Chemiluminescence Immunoassay)
hs-cTnI Rapid Quantitative Test (Chemiluminescence Immunoassay)
hs-cTnI Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the high sensitivity cardiac troponin I (hs-cTnI) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.
Biotime fT3 Rapid Quantitative Test
FT3 Rapid Quantitative Test (Fluorescence Immunoassay)
The Biotime FT3 Rapid Quantitative Test is intended to quantify the concentration of FT3 in human serum on the Biotime FIA Analyzer (Semi-automatic / Automatic) by fluorescent immunoassay. The test is used as an aid in the detection of hyperthyroidism. -Fluorescence immunoassay -hyperthyroidism For in vitro diagnostic use only. For professional use only.
Biotime HLC-100 Fully Automated HbA1c Analyzer
HLC-100 Fully Automated HbA1c Analyzer
Biotime’s HLC-100 Fully Automated HbA1c Analyzer provides a prompt, reliable solution for diabetes diagnosis. It utilizes the high performance liquid chromatography (HPLC) analytical technique, a gold standard that helps detect glycosylated hemoglobin (HbA1c) with superior precision. Its capability to measure HbA1c, HbF, and other hemoglobin fragments enables clinicians to make quick, accurate diagnoses, thus facilitating timely treatment for the patient.
Biotime D Dimer Chronic heart failure
D-Dimer Rapid Quantitative Test
Biotime D-Dimer test kit (Analyzer + Test cassette) is performed to help rule out Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) and stroke. It can perform the test accurately and rapidly within 3 min with the Biotime immunofluorescence analyzer.
Biotime 2 in 1 (CEA/AFP) Rapid Quantitative Test
2 in 1 (CEA/AFP) Rapid Quantitative Test
Biotime 2 in 1 (CEA/AFP) test kit has very important guiding significance in the diagnosis of liver cancer and can improve the accuracy of clinical diagnosis.
Toxoplasma IgG/IgM Rapid Test (Fluorescence Immunoassay)
Toxoplasma IgG/IgM Rapid Test (Fluorescence Immunoassay)
TheToxoplasma IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies toToxoplasma gondii in human serum.IgG results with this assay are used to indicate past or recent infection withToxoplasma gondii. IgM results obtained with this assay are used as an aid in the diagnosis of acute or recentToxoplasma gondii infections. Toxoplasma IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Toxoplasma gondii infection -For in vitro diagnostic use only. For professional use only.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact